Search clinical trials for: HRS8807

Total 5 results

Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer

ER-Positive, HER2-Negative Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects

Pain

China
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects

Pain
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.

Pain

China
Atridia Pty Ltd.

Completed

A Trial of HRS4800 Tables in Healthy Male Subjects

Pain

Australia

3

Subscribe